Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?

Cancers - Switzerland
doi 10.3390/cancers6020684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Association Between Circulating Tumor Cells and Peripheral Blood Monocytes in Metastatic Breast Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

Cancers
Cancer ResearchOncology
2020English

Circulating Tumor and Endothelial Cells as Predictors of Response in Metastatic Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2007English

Circulating Tumor Cells in Breast Cancer Beyond the Genotype of Primary Tumor for Tailored Therapy

International Journal of Cancer
Cancer ResearchOncology
2015English

Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution During Therapy for Metastatic Breast Cancer

Science Translational Medicine
Medicine
2015English

Neutrophils Help Circulating Tumor Cells Metastasize

Cancer Discovery
Oncology
2019English

Circulating Tumor Cells in Patients With Breast Cancer Dormancy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2019English

Impact of Systemic Therapy on Circulating Leukocyte Populations in Patients With Metastatic Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy